Altiora Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$823K Sell
895
-8
-0.9% -$8.11K 0.14% 59
2025
Q4
$970K Sell
903
-41
-4% -$39.2K 0.17% 53
2025
Q3
$720K Hold
944
0.13% 54
2025
Q2
$736K Hold
944
0.14% 54
2025
Q1
$780K Sell
944
-30
-3% -$25K 0.17% 52
2024
Q4
$752K Buy
974
+336
+53% +$278K 0.16% 54
2024
Q3
$565K Hold
638
0.13% 66
2024
Q2
$578K Buy
638
+41
+7% +$32.8K 0.14% 59
2024
Q1
$464K Sell
597
-16
-3% -$11.4K 0.13% 60
2023
Q4
$357K Buy
613
+159
+35% +$92.8K 0.1% 62
2023
Q3
$244K Buy
+454
New +$234K 0.11% 53

Other funds holding LLY

Altiora Financial Group's LLY Position: Q1 2026 in Review

Altiora Financial Group reduced its Eli Lilly (LLY) stake by 0.89% in Q1 2026, selling an estimated $8.11K and leaving 895 shares worth $823K. The position accounts for 0.14% of the portfolio, ranked #59.

Altiora Financial Group first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $970K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Altiora Financial Group held 895 shares of Eli Lilly worth $823K as of Q1 2026.
  • Altiora Financial Group sold 8 Eli Lilly shares in Q1 2026, an estimated $8.11K.
  • Eli Lilly made up 0.14% of Altiora Financial Group's portfolio in Q1 2026, its #59 holding.
  • Altiora Financial Group first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • Altiora Financial Group's Eli Lilly position peaked at $970K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Altiora Financial Group's 13F filing for Q1 2026, filed 8 May 2026.